Rhythm Pharmaceuticals buy Guggenheim
Start price
06.08.25
/
50%
€77.50
Target price
06.08.26
€103.73
Performance (%)
27.10%
End price
07.08.26
€98.50
Summary
This prediction ended on 07.08.26 with a price of €98.50. The prediction had a final performance of 27.10%. Guggenheim has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Rhythm Pharmaceuticals | -1.508% | -1.508% | 15.976% |
| iShares Core DAX® | -0,05 % | 5,96 % | 7,40 % |
| iShares Nasdaq 100 | 0,92 % | 3,69 % | 28,14 % |
| iShares Nikkei 225® | 3,01 % | 6,64 % | 48,89 % |
| iShares S&P 500 | -0,36 % | 2,75 % | 22,53 % |
Comments by Guggenheim for this prediction
In the thread Rhythm Pharmaceuticals diskutieren
Rhythm Pharmaceuticals, Inc. (NASDAQ: RYTM) had its price target raised by analysts at Guggenheim from $119.00 to $120.00. They now have a "buy" rating on the stock.
Ratings data for RYTM provided by MarketBeat
In the thread Trading Rhythm Pharmaceuticals
Die von Guggenheim gewählte maximale Laufzeit wurde überschritten
Stopped prediction by Guggenheim for Rhythm Pharmaceuticals
Rhythm Pharmaceuticals
Start price
Target price
Perf. (%)
€75.50
10.07.25
10.07.25
-
10.07.26
10.07.26
23.18%
11.07.26
11.07.26
Rhythm Pharmaceuticals
Start price
Target price
Perf. (%)
€46.40
21.10.24
21.10.24
€64.45
21.10.25
21.10.25
95.04%
22.10.25
22.10.25